Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 81 - 90 of 122 results for "Biotech"

Former company director pleads guilty to dishonest conduct

CLAIRE MCGREAL  |  THURSDAY, 6 OCT 2011
... investors between January 2003 and April 2007 through his companies, Financial Partners, Venture Capital Management, and Biotech Solutions. None of the companies held an Australian financial services (AFS) license at the time. Finnigan told investors ...

Market Wrap - Morning

AAP  |  MONDAY, 12 SEP 2011
US stocks plunged on Friday, with the Dow Jones Industrial Average sliding more than 300 points, as global stock markets were stung by fresh anxiety in the eurozone over Greece's bailout. The Dow fell 303.68 points (2.69 per cent) to close at 10,992.13. ...

Market Wrap - Midday

AAP  |  MONDAY, 18 APR 2011
... the healthcare sector over the last few years, people have taken it as a safe haven," Ms Cox said. Pharmaceutical and biotech company CSL Ltd was up 45 cents at $35.35 by 1210 AEST. At 1213 AEST, the price of spot gold in Sydney was $US1485.78, up $US9.98 ...

Market Wrap - Midday

AAP  |  FRIDAY, 1 APR 2011
The Australian stock market was more than half a per cent higher at noon as speculation re-emerged that Shell could sell its stake in Woodside to BHP. At 1200 AEDT, the benchmark S&P/ASX200 index was 28.4 points higher, or 0.59 per cent, at 4,866.3 ...

Market wrap

AAP  |  THURSDAY, 17 FEB 2011
The Australian market is receiving clear, positive leads from offshore trading overnight, with all three key Wall Street indices substantially higher, as were European and Asian markets. Gold was flat but higher, oil was higher, but silver and copper ...

Bell Potter faces $22m class action

ELISE BURGESS  |  FRIDAY, 3 DEC 2010
... The class action, held in the Federal Court of Australia, alleges that Bell Potter encouraged clients to buy shares in biotech company, Progen Pharmaceuticals (PGL) in 2007. Shortly after, Bell Potter was appointed as co-underwriter of a capital raising ...

ASIC bans adviser and charges former director

ELISE BURGESS  |  WEDNESDAY, 10 NOV 2010
... separate charges after allegedly raising funds from nine investors through Financial Partners, Venture Capital Management and Biotech Solutions before allegedly depositing the money into bank accounts he controlled, using the funds for the three companies ...

Market Wrap - Morning

AAP  |  THURSDAY, 7 OCT 2010
... Treasury notes. In company news, WPG Resources Ltd executive chairman Bob Duffin will address a Sydney Mining Club luncheon. Biotech company Broadvector Ltd is scheduled to list on the Australian Stock Exchange. On Wednesday, Australian stocks touched ...

Temasek invests $50m in renewable fuels

MICHAEL HOBBS  |  THURSDAY, 8 APR 2010
Singapore sovereign wealth fund (SWF), Temasek Holdings, has invested $50 million in Californian-based renewable chemicals and fuel start-up company, Amyris Biotechnologies. The company will use the funds to support commercial plant design and construction ...

Platinum snubs US healthcare reforms

MICHAEL HOBBS  |  FRIDAY, 26 MAR 2010
... they have underpins their valuation." Rather, the investment team is targeting companies that attract business from Asia. Biotech stocks remain a focus. "We see biotech companies as the engine for these big pharmaceuticals firms so we've kept them even ...